Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Randomized Phase II Study of Atezolizumab and A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC), HCRN GI19-405
Sponsored by Hoosier Cancer Research Network, Inc.
$112.9K Funding
6 People
External
Related Topics
cancer,
immunotherapy,
clinical trial,
hepatocellular carcinoma,
treatment
People
Gustavo Cornejo
(CD)
Senior VP Health Sciences
﹒Research Compliance Administrator III
Gregory Woodhead
Principal Investigator (PI)
Medical Imaging
﹒Assistant Professor
Hina Arif Tiwari
Co-Investigator (COI)
Pathology and Lab Medicine
﹒Professor
Junaid Arshad
Co-Investigator (COI)
Medicine
﹒Assistant Professor, Medicine - (Clinical Scholar Track)
Rachna Shroff
Co-Investigator (COI)
Medicine
﹒Professor
Umbreen Rozell
Co-Investigator (COI)
Medicine
﹒Assistant Clinical Professor, Medicine - (Clinical Series Track)
